FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
Position in PFE — Pfizer Inc
CIK 1009016
Cincinnati, OH
Position in PFE
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$57,340,455
+$9,058,633 QoQ
Shares Held
2,042,039
+5.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.46597493975385.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5340250602461559.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ holds $685,312,998 across 9 Drug Manufacturers - General names. PFE ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,064,304 | $260,158,469 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,605,927 | $158,049,472 | |
| 3 | MRK |
Merck & Co., Inc.
|
659,851 | $79,373,476 | |
| 4 | PFE |
Pfizer Inc
This page
|
2,042,039 | $57,340,455 | |
| 5 | LLY |
ELI LILLY & Co
|
52,225 | $48,034,988 | |
| 6 | ABBV |
AbbVie Inc.
|
207,858 | $45,207,035 | |
| 7 | AMGN |
Amgen Inc
|
92,090 | $32,401,865 | |
| 8 | NVS |
Novartis AG
|
29,042 | $4,436,165 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,340,455 | 2,042,039 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $48,281,822 | 1,939,029 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $48,225,053 | 1,892,663 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $41,249,620 | 1,701,717 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $42,642,684 | 1,682,821 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $43,227,663 | 1,629,388 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $46,501,544 | 1,606,826 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $44,764,614 | 1,599,879 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $47,653,021 | 1,717,226 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $49,293,719 | 1,712,182 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $56,068,080 | 1,690,325 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $38,102,120 | 1,038,771 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $32,818,663 | 804,379 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $46,036,321 | 898,445 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $39,175,571 | 895,237 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $46,937,275 | 895,237 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $45,632,873 | 881,454 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $59,909,059 | 1,014,548 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $67,398,519 | 1,567,043 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $14,017,791 | 357,962 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $12,945,413 | 357,312 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $12,940,003 | 351,535 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $11,794,964 | 338,744 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $10,273,364 | 331,135 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $10,254,489 | 331,135 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||